Next Article in Journal
Persistent Roseoloviruses Infection in Adult Patients with Epilepsy
Next Article in Special Issue
Molecular Interventions towards Multiple Sclerosis Treatment
Previous Article in Journal
Cellular Localization of gdnf in Adult Zebrafish Brain
Previous Article in Special Issue
Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know

This is an early access version, the complete PDF, HTML, and XML versions will be available soon.

Open AccessEditorial

The Long Road of Immunotherapeutics against Multiple Sclerosis

1
Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia
2
Neurology Department, Thomas Jefferson University, Philadelphia, Pennsylvania, PA-19107, USA
3
NewDrug, Patras Science Park, 26500 Patras, Greece
*
Author to whom correspondence should be addressed.
This Editorial is dedicated to Elizabeth Matsoukas who was the inspiration of the research.
Brain Sci. 2020, 10(5), 288; https://doi.org/10.3390/brainsci10050288
Received: 24 April 2020 / Accepted: 26 April 2020 / Published: 11 May 2020
(This article belongs to the Special Issue Advances in Multiple Sclerosis Research)
This commentary highlights novel immunomodulation and vaccine-based research against multiple sclerosis (MS) and reveals the amazing story that triggered this cutting-edge MS research in Greece and worldwide. It further reveals the interest and solid support of some of the world’s leading scientists, including sixteen Nobel Laureates who requested from European leadership to take action in supporting Greece and its universities in the biggest ever financial crisis the country has encountered in the last decades. This support endorsed vaccine-based research on MS, initiated in Greece and Australia, leading to a worldwide network aiming to treat or manage disease outcomes. Initiatives by bright and determined researchers can result in frontiers science. We shed light on a unique story behind great research on MS which is a step forward in our efforts to develop effective treatments for MS.
Keywords: multiple sclerosis; MS; vaccine; immunomodulation; carriers multiple sclerosis; MS; vaccine; immunomodulation; carriers
MDPI and ACS Style

Apostolopoulos, V.; Rostami, A.; Matsoukas, J. The Long Road of Immunotherapeutics against Multiple Sclerosis. Brain Sci. 2020, 10, 288.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop